Legal Opinion
Momenta Pharm., Inc. v. Amphastar Pharm., Inc.
District Court, District of Columbia
Decided July 13, 2018No. Civil Action No. 11-11681-NMGPublishedCited by 4 opinions
1Opinion of the CourtGorton, J.
*143In July, 2017, after a nine-day jury trial, a jury found that defendants Amphastar Pharmaceuticals, Inc. and International Medication Systems, Ltd. (collectively, "Amphastar" or "defendants") infringed the patent held by plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc. (collectively, "Momenta" or "plaintiffs") during the course of defendants' manufacture and sale of generic enoxaparin. The jury also found, however, that the infringed patent claims were invalid because they were not enabled and had inadequate written descriptions.
The instant dispute involves the surety bond posted by…
2Cases cited5 opinions
- Global NAPs, Inc. v. Verizon New England, Inc.Court of Appeals for the First Circuit · 2007
- The Continuum Company, Inc. v. Incepts, Inc., Abs Ventures Ii, and Aba Excelsior IICourt of Appeals for the Fifth Circuit · 1989
- Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc.Court of Appeals for the Federal Circuit · 2012
- Momenta Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA Inc.Court of Appeals for the Federal Circuit · 2015
- Pabst Brewing Co. v. CorraoDistrict Court, E.D. Wisconsin · 1998
3Cited by4 opinions
- Axia Netmedia Corp. v. Mass. Tech. Park Corp.District Court, District of Columbia · 2018
- Axia NetMedia Corporation v. Massachusetts Technology Park CorporationDistrict Court, D. Massachusetts · 2018
- Broker Genius Inc. v. Seat Scouts LLCDistrict Court, S.D. New York · 2019
- NATIONAL COLLEGIATE ATHLETIC ASSOCIATION v. CHRISTIEDistrict Court, D. New Jersey · 2020